611 related articles for article (PubMed ID: 27031690)
1. Molecular pathogenesis of hereditary hemochromatosis.
Liu J; Pu C; Lang L; Qiao L; Abdullahi MA; Jiang C
Histol Histopathol; 2016 Aug; 31(8):833-40. PubMed ID: 27031690
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
Kawabata H
Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618
[TBL] [Abstract][Full Text] [Related]
3. [Non-HFE-related hereditary iron overload].
Aguilar-Martinez P
Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
[TBL] [Abstract][Full Text] [Related]
4. Non-HFE hemochromatosis.
Pietrangelo A
Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
[TBL] [Abstract][Full Text] [Related]
5. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.
Pietrangelo A
Gastroenterology; 2010 Aug; 139(2):393-408, 408.e1-2. PubMed ID: 20542038
[TBL] [Abstract][Full Text] [Related]
6. The molecular pathogenesis of hereditary hemochromatosis.
Babitt JL; Lin HY
Semin Liver Dis; 2011 Aug; 31(3):280-92. PubMed ID: 21901658
[TBL] [Abstract][Full Text] [Related]
7. Non-HFE hepatic iron overload.
Pietrangelo A; Caleffi A; Corradini E
Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
[TBL] [Abstract][Full Text] [Related]
9. Non-HFE haemochromatosis.
Wallace DF; Subramaniam VN
World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
[TBL] [Abstract][Full Text] [Related]
10. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
[TBL] [Abstract][Full Text] [Related]
11. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.
Pietrangelo A
Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis.
Wang Y; Du Y; Liu G; Guo S; Hou B; Jiang X; Han B; Chang Y; Nie G
Int J Hematol; 2017 Apr; 105(4):521-525. PubMed ID: 27896572
[TBL] [Abstract][Full Text] [Related]
13. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnostic and pathogenesis of hereditary hemochromatosis.
Santos PCJL; Krieger JE; Pereira AC
Int J Mol Sci; 2012; 13(2):1497-1511. PubMed ID: 22408404
[TBL] [Abstract][Full Text] [Related]
15. Hereditary hemochromatosis and transferrin receptor 2.
Chen J; Enns CA
Biochim Biophys Acta; 2012 Mar; 1820(3):256-63. PubMed ID: 21864651
[TBL] [Abstract][Full Text] [Related]
16. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
[TBL] [Abstract][Full Text] [Related]
17. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F
Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease.
Sandhu K; Flintoff K; Chatfield MD; Dixon JL; Ramm LE; Ramm GA; Powell LW; Subramaniam VN; Wallace DF
Blood; 2018 Jul; 132(1):101-110. PubMed ID: 29743178
[TBL] [Abstract][Full Text] [Related]
19. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
[TBL] [Abstract][Full Text] [Related]
20. DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway.
Li Y; Xu A; Ouyang Q; Zhang W; Zhang C; Chen Z; Zhou D; Zhang B; Duan W; Zhao X; Wang X; You H; Ou X; Jia J; Huang J
Hepatol Int; 2023 Jun; 17(3):648-661. PubMed ID: 36729283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
